Chang Dai

621 total citations
17 papers, 450 citations indexed

About

Chang Dai is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Ophthalmology. According to data from OpenAlex, Chang Dai has authored 17 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Ophthalmology. Recurrent topics in Chang Dai's work include Retinal Diseases and Treatments (5 papers), Retinopathy of Prematurity Studies (5 papers) and Ferroptosis and cancer prognosis (3 papers). Chang Dai is often cited by papers focused on Retinal Diseases and Treatments (5 papers), Retinopathy of Prematurity Studies (5 papers) and Ferroptosis and cancer prognosis (3 papers). Chang Dai collaborates with scholars based in China, United States and Germany. Chang Dai's co-authors include Zheng Xiao, Jin Fang, Wei Shuai, Bin Kong, He Huang, Guanfang Su, He Huang, Wei Li, Jun Zhu and Gong Yang and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Chang Dai

16 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chang Dai China 12 233 188 118 49 49 17 450
Berta Raposo Spain 8 296 1.3× 102 0.5× 52 0.4× 94 1.9× 16 0.3× 9 549
Nabil A. Rashdan United States 13 197 0.8× 58 0.3× 48 0.4× 80 1.6× 16 0.3× 18 460
Krissanapong Manotham Thailand 12 215 0.9× 98 0.5× 144 1.2× 54 1.1× 54 1.1× 24 615
Shubin Hong China 15 282 1.2× 60 0.3× 211 1.8× 16 0.3× 17 0.3× 44 650
Yozo Mitsui Japan 18 375 1.6× 311 1.7× 236 2.0× 27 0.6× 92 1.9× 66 864
Izabela Florek Poland 4 167 0.7× 39 0.2× 62 0.5× 52 1.1× 17 0.3× 14 346
Geniece M. Lehmann United States 11 212 0.9× 55 0.3× 58 0.5× 7 0.1× 50 1.0× 11 502
Mette L. Johansen United States 12 195 0.8× 92 0.5× 46 0.4× 106 2.2× 50 1.0× 18 671

Countries citing papers authored by Chang Dai

Since Specialization
Citations

This map shows the geographic impact of Chang Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang Dai more than expected).

Fields of papers citing papers by Chang Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang Dai. The network helps show where Chang Dai may publish in the future.

Co-authorship network of co-authors of Chang Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Chang Dai. A scholar is included among the top collaborators of Chang Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang Dai. Chang Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Xiao, Zheng, et al.. (2024). Ubiquitin specific protease 38 aggravates pathological cardiac remodeling by stabilizing phospho-TBK1. International Journal of Biological Sciences. 20(5). 1815–1832. 9 indexed citations
2.
Liang, Wenkai, Miao Xie, Dong Sheng Li, et al.. (2024). Plasmon‐Promoted Interatomic Hot Carriers Regulation Enhanced Electrocatalytic Nitrogen Reduction Reaction. Angewandte Chemie International Edition. 63(48). e202409484–e202409484. 8 indexed citations
3.
Liu, Qi, Bin Kong, Wei Shuai, et al.. (2023). From consumption to withdrawal: A broad synopsis of the effects of alcohol. SHILAP Revista de lepidopterología. 1(4). 330–339.
4.
Dai, Chang, Jun Xiao, Chenguang Wang, Wei Li, & Guanfang Su. (2022). Neurovascular abnormalities in retinopathy of prematurity and emerging therapies. Journal of Molecular Medicine. 100(6). 817–828. 12 indexed citations
5.
Dai, Chang, Hong Tian, Amit Bhatt, et al.. (2022). Secretogranin III stringently regulates pathological but not physiological angiogenesis in oxygen-induced retinopathy. Cellular and Molecular Life Sciences. 79(1). 63–63. 14 indexed citations
6.
Dai, Chang, Bin Kong, Wei Shuai, et al.. (2022). Dapagliflozin Reduces Pulmonary Vascular Damage and Susceptibility to Atrial Fibrillation in Right Heart Disease. ESC Heart Failure. 10(1). 578–593. 14 indexed citations
7.
Dai, Chang, Hong Tian, Amit Bhatt, et al.. (2022). Safety and Efficacy of Systemic Anti-Scg3 Therapy to Treat Oxygen-Induced Retinopathy. Frontiers in Bioscience-Landmark. 27(4). 130–130. 3 indexed citations
8.
Kong, Bin, Chang Dai, Zheng Xiao, et al.. (2022). Protective effects of Dapagliflozin on the vulnerability of ventricular arrhythmia in rats with pulmonary artery hypertension induced by monocrotaline. Bioengineered. 13(2). 2697–2709. 17 indexed citations
9.
Dai, Chang, Keith A. Webster, Amit Bhatt, et al.. (2021). Concurrent Physiological and Pathological Angiogenesis in Retinopathy of Prematurity and Emerging Therapies. International Journal of Molecular Sciences. 22(9). 4809–4809. 38 indexed citations
10.
Tian, Hong, Chang Dai, Rong Wen, et al.. (2021). Optimal Efficacy and Safety of Humanized Anti-Scg3 Antibody to Alleviate Oxygen-Induced Retinopathy. International Journal of Molecular Sciences. 23(1). 350–350. 4 indexed citations
11.
Fang, Jin, Bin Kong, Wei Shuai, et al.. (2021). Ferroportin-mediated ferroptosis involved in new-onset atrial fibrillation with LPS-induced endotoxemia. European Journal of Pharmacology. 913. 174622–174622. 52 indexed citations
12.
Wu, Tong, Sheng Yun, Yuanyuan Qin, et al.. (2021). Bile duct ligation causes opposite impacts on the expression and function of BCRP and P-gp in rat brain partly via affecting membrane expression of ezrin/radixin/moesin proteins. Acta Pharmacologica Sinica. 42(11). 1942–1950. 14 indexed citations
13.
Dai, Chang, Bin Kong, Zheng Xiao, et al.. (2021). Inhibition of ferroptosis reduces susceptibility to frequent excessive alcohol consumption-induced atrial fibrillation. Toxicology. 465. 153055–153055. 48 indexed citations
14.
Xiao, Zheng, Bin Kong, Jin Fang, et al.. (2021). Ferrostatin-1 alleviates lipopolysaccharide-induced cardiac dysfunction. Bioengineered. 12(2). 9367–9376. 150 indexed citations
15.
Xiao, Zheng, Bin Kong, Hongjie Yang, et al.. (2020). Key Player in Cardiac Hypertrophy, Emphasizing the Role of Toll-Like Receptor 4. Frontiers in Cardiovascular Medicine. 7. 579036–579036. 25 indexed citations
16.
Dai, Chang, Qiaoyun Gong, Yan Cheng, & Guanfang Su. (2019). Regulatory mechanisms of Robo4 and their effects on angiogenesis. Bioscience Reports. 39(7). 31 indexed citations
17.
Xu, Libo, Jinguo Wang, Baofeng Guo, et al.. (2017). Comparison of clinical and survival characteristics between prostate cancer patients of PSA-based screening and clinical diagnosis in China. Oncotarget. 9(1). 428–441. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026